Topic
ifinatamab deruxtecan
1 market across Kalshi and Polymarket, $496 traded today.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
 FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)EconomicsEnds Dec 31, 2026 | 87% | — |  98¢ | $496 |
Topic
1 market across Kalshi and Polymarket, $496 traded today.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
| FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)EconomicsEnds Dec 31, 2026 | 87% | — | 98¢ | $496 |